Home » News » Awards & Advancement » Saint Luke’s Cancer Institute appoints new medical director

Saint Luke’s Cancer Institute appoints new medical director

Friday, July 26, 2013

Saint Luke’s Cancer Institute (SLCI) has appointed Timothy J. Pluard, M.D., medical director. Pluard is associate professor of medicine at Washington University and clinical director, section of breast oncology at Siteman Cancer Center, a National Cancer Institute (NCI) designated Comprehensive Cancer Center, at Washington University/Barnes Jewish Hospital in Saint Louis, Mo.

Pluard was recruited by Siteman Cancer Center in 2005 as medical director of its first satellite center in St. Peters, Mo. In 2010, Pluard was appointed clinical director of breast oncology. He also was the institutional Principal Investigator for the National Surgical Adjuvant Breast and Bowel Project (NSABP) as well as all breast industry research trials. Pluard led multiple clinical trials at Siteman Cancer Center over the past eight years, and he has been recognized twice by NCI as one of the nation’s top accruers in cooperative group trials.

Pluard will work to maximize growth on a regional and national level and pursue research opportunities and clinical trials.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!